The global medical imaging phantoms market size is anticipated to reach USD 212.4 million by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 5.2% from 2020 to 2027. Diagnostic radiology is widely adopted for precision diagnosis of brain injuries, cancer, and other diseases. In addition, computed tomography (CT) scan and magnetic resonance imaging (MRI) are widely used techniques. These phantoms help in enhancing the efficiency of these imaging devices by helping medical experts in detecting, interpreting, analyzing, and evaluating information required for treatments. Therefore, the increasing adoption of these devices for the diagnosis of severe diseases is expected to drive the market growth.
Effective reimbursement scenario of medical imaging and growing competition to provide advanced technologies are a few factors driving the adoption of the product. Moreover, the growing participation of key players in various radiology conferences is expected to drive the adoption of these devices and their respective phantoms. The increasing number of preclinical studies to understand the effectiveness of these phantoms for hybrid imaging devices is expected to expand the growth potential in the coming years.
The introduction of advanced materials and production techniques are some of the major factors expected to strengthen the applications of these phantoms for specific diseases. The introduction of advanced simulating phantoms is anticipated to provide deep insights on actual dynamics at a cellular level, thus enhancing the precision in diagnostics.
These devices have various associated advantages, which is a key factor driving the market growth. For instance, realistic medical imaging phantoms of organs and tissues are being developed using 3D technology to enhance the performance of medical imaging devices. This, in turn, is expected to drive the medical imaging phantom market growth over the forecast period.
Request a free sample copy or view report summary: Medical Imaging Phantom Market Report
X-ray phantoms held the largest market share in 2019 mainly due to the growing number of x-ray unit launches in various countries
Nuclear imaging phantoms is projected to register the highest CAGR over the forecast period owing to the growing adoption of nuclear medicine. In addition, increasingly advanced and safer radionuclides and high accuracy of nuclear imaging modality are some factors contributing towards the segment growth
Hospitals dominated the market in 2019 owing to a significant number of favorable government initiatives to improve the quality of treatment offered to patients, and the steep rise in medical reimbursement policies
The academic and research institutes segment is expected to witness steady growth from 2020 to 2027 owing to high product demand for educational purposes for providing efficient training regarding the usage of these phantoms
North America held the largest share in 2019 owing to the high adoption of advanced medical products, increasing government expenditure for research activities, and a growing number of product launches in the region
The major players present in the medical imaging phantom market include Biodex Medical Systems, Inc.; Modus Medical Devices Inc.; Carville Limited; PTW Freiburg GmbH; Dielectric Corporation; Quart GmbH; Kyoto Kagaku Co. Ltd; and Leeds Test Objects Ltd.
Grand View Research has segmented the global medical imaging phantoms market on the basis of device type, end-use, material, and region:
Medical Imaging Phantom Device Type Outlook (Volume, ’000; Revenue, USD Million, 2016 - 2027)
X-ray
Ultrasound
CT
MRI
Nuclear Imaging
Others
Medical Imaging Phantom End-use Outlook (Revenue, USD Million, 2016 - 2027)
Hospitals
Academic and Research Institutes
Diagnostic and Reference Laboratories
Medical Device Companies
Medical Imaging Phantom Material Outlook (Volume, ’000 Units; Revenue, USD Million, 2016 - 2027)
Simulating Devices
X-ray
Ultrasound
CT
MRI
Nuclear Imaging
Others
False Organs
X-ray
Ultrasound
CT
MRI
Nuclear Imaging
Others
Medical Imaging Phantom Regional Outlook (Volume, ’000 Units; Revenue, USD Million, 2016 - 2027)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Russia
Netherlands
Switzerland
Turkey
Poland
Asia Pacific
China
Japan
India
Thailand
South Korea
Indonesia
Taiwan
Hong Kong
Philippines
Malaysia
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Qatar
"The quality of research they have done for us has been excellent..."